Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Occurrence and Resolution of Anthracycline Cardiotoxicity and Impact on Treatment Outcomes Among Children Treated on the AAML1031 Clinical Trial: A Report from the Children's Oncology Group

Kelly D Getz, Lillian Sung, MD PhD, Robert B. Gerbing, Todd A. Alonzo, PhD, Yimei Li, PhD, Yuan-Shung V. Huang, MS, Kasey J Leger, MD MSc, Jessica A. Pollard, MD, Todd M Cooper, DO, Edward Anders Kolb, MD, Alan S Gamis, MD MPH, Richard Aplenc, MD PhD

Blood (2019) 134 (Supplement_1): 331.

https://doi.org/10.1182/blood-2019-131227

Published: 2019

Journal Articles

High-Dose Cytarabine Is Indispensable for the Survival of Children with Myeloid Leukemia of Down Syndrome Despite Negative Minimal Residual Disease Post-Induction

Johann K. Hitzler, MD, Jason Berman, MD, Robert B. Gerbing, Amy Beckman, Betsy A Hirsch, PhD, Susana C. Raimondi, PhD, Todd E Druley, MD PhD, Michael R. Loken, PhD, Lisa Eidenschink Brodersen, PhD, Karen Chisholm, Shelton A. Viola, MD, Jeffrey W. Taub, MD, Alan S Gamis, MD MPH, Todd A. Alonzo, PhD, E. Anders Kolb, MD

Blood (2019) 134 (Supplement_1): 118.

https://doi.org/10.1182/blood-2019-126723

Published: 2019

Journal Articles

Mitoxantrone in Combination with Clofarabine (MITCL) in Children, Adolescents and Young Adults with Refractory/Relapsed Acute Leukemia

Jessica C. Hochberg, MD, Javier Oesterheld, MD, Allyson M. Flower, MD, Liana Klejmont, Pharm D, Gregory Hemenway, MS2, Lauren Harrison, RN, MSN, Qiuhu Shi, PhD, Mitchell S. Cairo, MD

Blood (2017) 130 (Supplement 1): 3893.

https://doi.org/10.1182/blood.V130.Suppl_1.3893.3893

Published: 2017

Journal Articles

Effect of Dexrazoxane on Heart Function Among Long-Term Survivors of Childhood Leukemia and Lymphoma: A Report from the Children's Oncology Group (COG)

Eric J Chow, MD MPH, David R. Doody, MS, Saro H. Armenian, DO, MPH, Sanjeev Aggarwal, MD, K. Scott Baker, MD MS, Smita Bhatia, MD MPH, Nancy A. Blythe, BA, Louis S. Constine, MD, David R. Freyer, DO, MS, Lisa M. Kopp, DO, Wendy M. Leisenring, ScD, Nao Sasaki, MD, Lynda M. Vrooman, MD MSc, Barbara L. Asselin, MD, Cindy L. Schwartz, MD MPH, Steven E. Lipshultz, MD FAAP, FAHA

Blood (2016) 128 (22): 696.

https://doi.org/10.1182/blood.V128.22.696.696

Published: 2016

Journal Articles

A Pilot Study of Mitoxantrone in Combination with Clofarabine (MITCL) in Children, Adolescents and Young Adults (CAYA) with Refractory/Relapsed Acute Leukemia

Jessica C. Hochberg, MD, Javier Oesterheld, MD, Olga Miitano, PharmD, Lauren Harrison, RN, MSN, Mitchell S. Cairo, MD

Blood (2015) 126 (23): 2499.

https://doi.org/10.1182/blood.V126.23.2499.2499

Published: 2015

Journal Articles

Dexrazoxane Does Not Negatively Impact Survival Outcomes in Children and Young Adults with Acute Myeloid Leukemia (AML)

Nathan J. Schloemer, MD, Molly M. Brickler, RN, MSN, CPNP-AC, Vanessa C. McFadden, MD PhD, Yumei Cao, PhD, Raymond G. Hoffmann, PhD, Joseph R. Block, MD, Richard L. Tower, II, MD MS, Michael J. Burke, MD

Blood (2015) 126 (23): 4886.

https://doi.org/10.1182/blood.V126.23.4886.4886

Published: 2015

Journal Articles

Phase Ib Trial of the mTOR Inhibitor Everolimus Given in Combination with Multiagent Chemotherapy in Relapsed Acute Lymphoblastic Leukemia

Andrew E. Place, MDPhD, Yana Pikman, MD, Kristen Stevenson, MS, Marian H. Harris, MD PhD, Todd M. Cooper, DO, Lia Gore, MD, Nobuko Hijiya, MD, Mignon L. Loh, MD, Melinda Pauly, MD, Maria Luisa Sulis, MD, Donna S Neuberg, ScD, Kimberly Stegmaier, MD, Stephen E. Sallan, MD, Lewis B. Silverman, MD

Blood (2015) 126 (23): 3765.

https://doi.org/10.1182/blood.V126.23.3765.3765

Published: 2015

Journal Articles

Results Of The DFCI ALL Consortium Protocol 05-001 For Children and Adolescents With Newly Diagnosed ALL

Lewis B. Silverman, MD, Kristen E. Stevenson, MS, Uma H. Athale, M.D., M.Sc., Luis A. Clavell, MD, Peter Cole, MD, Kara A. Kelly, MD, Jean-Marie Leclerc, MD, Bruno Michon, MD, FRCPC, Marshall A. Schorin, MD, Cindy L Schwartz, MD, MPH, Barbara Asselin, MD, Jeffrey G Supko, PhD, Sarah Hunt, MPH, Place Andrew, MD, PhD, Lynda M. Vrooman, MD, Donna S. Neuberg, ScD, Stephen E. Sallan, MD

Blood (2013) 122 (21): 838.

https://doi.org/10.1182/blood.V122.21.838.838

Published: 2013

Journal Articles

Dexrazoxane Use in Pediatric Patients with Acute Lymphoblastic or Myeloid Leukemia: Analysis of a National Cohort of Patients in the Pediatric Health Information Systems Database From 1999 to 2009

Dana Sepe, MD, Brian T. Fisher, DO, MSCE, Alix E. Seif, MD, MPH, Yuan-Shung V. Huang, MS, Yimei Li, PhD, Richard Aplenc, MD, PhD

Blood (2011) 118 (21): 4242.

https://doi.org/10.1182/blood.V118.21.4242.4242

Published: 2011

Journal Articles

Vitamin E Does Not Reduce Cardiomyopathy In Doxorubicin treated Rats

Jhon A Guerra, MD, FAAP, Maribel Torres-Serrant, MD, Pedro J Santiago, MD

Blood (2010) 116 (21): 4944.

https://doi.org/10.1182/blood.V116.21.4944.4944

Published: 2010

Journal Articles

Transfusional Iron Overload: An Underappreciated Danger in AML Patients?

Jacob Rozmus, MD, FRCPC, Louis D. Wadsworth, MBChB, FRCP, John K. Wu, MBBS, FRCPC

Blood (2009) 114 (22): 4133.

https://doi.org/10.1182/blood.V114.22.4133.4133

Published: 2009

Journal Articles

Prevention Effects of Schisandrin B on Cardiotoxicity Induced by Anthracyclines in Rabbit Model

Caigang Xu, Feifei Che, Juan Xu, Yu Liu

Blood (2008) 112 (11): 5030.

https://doi.org/10.1182/blood.V112.11.5030.5030

Published: 2008

Journal Articles

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

Albert Moghrabi, Donna E. Levy, Barbara Asselin, Ronald Barr, Luis Clavell, Craig Hurwitz, Yvan Samson, Marshall Schorin, Virginia K. Dalton, Steven E. Lipshultz, Donna S. Neuberg, Richard D. Gelber, Harvey J. Cohen, Stephen E. Sallan, Lewis B. Silverman

Blood (2006) 109 (3): 896–904.

https://doi.org/10.1182/blood-2006-06-027714

Published: 2006

Journal Articles

Results of Randomized Study on Dexrazoxane Administration in Children with De Novo Acute Leukaemia.

Eva de Berranger, MD, Estelle Thebaud-Leculee, MD, Isabelle Wickaert, MD, Guy Vaksman, MD, Francoise Mazingue, MD, Charles Francart, MD, Jean-Hugues Dalle, MD, PhD, Brigitte Nelken, MD

Blood (2005) 106 (11): 4584.

https://doi.org/10.1182/blood.V106.11.4584.4584

Published: 2005

Journal Articles

Natriuretic Peptides in Children with Acute Lymphoblastic Leukaemia.

Teresa Jackowska, Robert Wasilewski, MD, Malgorzata Golabek, MD, Malgorzata Syczewska, PhD

Blood (2004) 104 (11): 4437.

https://doi.org/10.1182/blood.V104.11.4437.4437

Published: 2004

Journal Articles

Thrombopoietin Protects Against Cardiotoxicity Induced by Doxorubicin.

Rita Y.T. Sung, M.D., Wei Zhe Huang, M.D., Mo Yang, Ph.D., Nga Hin Pong, M.Phil., Shuk Man Lee, M.Phil., Wood Yee Chan, Ph.D., Yeuk Oi Wong, M.Phil., Da Wei Xiao, M.D., Man Yin To, B.Sc., Karen K.H. Li, Ph.D.

Blood (2004) 104 (11): 3310.

https://doi.org/10.1182/blood.V104.11.3310.3310

Published: 2004

Journal Articles

Outcome of Dana-Farber Cancer Institute (DFCI) Consortium Protocol 95–01 for Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL).

Lewis B. Silverman, MD, Donna E. Levy, MS, Virginia K. Dalton, MS, PNP, Steven E. Lipshultz, MD, Richard D. Gelber, PhD, Stephen E. Sallan, MD

Blood (2004) 104 (11): 679.

https://doi.org/10.1182/blood.V104.11.679.679

Published: 2004

NARROW

Occurrence and Resolution of Anthracycline Cardiotoxicity and Impact on Treatment Outcomes Among Children Treated on the AAML1031 Clinical Trial: A Report from the Children's Oncology Group

High-Dose Cytarabine Is Indispensable for the Survival of Children with Myeloid Leukemia of Down Syndrome Despite Negative Minimal Residual Disease Post-Induction

Mitoxantrone in Combination with Clofarabine (MITCL) in Children, Adolescents and Young Adults with Refractory/Relapsed Acute Leukemia

Effect of Dexrazoxane on Heart Function Among Long-Term Survivors of Childhood Leukemia and Lymphoma: A Report from the Children's Oncology Group (COG)

A Pilot Study of Mitoxantrone in Combination with Clofarabine (MITCL) in Children, Adolescents and Young Adults (CAYA) with Refractory/Relapsed Acute Leukemia

Dexrazoxane Does Not Negatively Impact Survival Outcomes in Children and Young Adults with Acute Myeloid Leukemia (AML)

Phase Ib Trial of the mTOR Inhibitor Everolimus Given in Combination with Multiagent Chemotherapy in Relapsed Acute Lymphoblastic Leukemia

Results Of The DFCI ALL Consortium Protocol 05-001 For Children and Adolescents With Newly Diagnosed ALL

Dexrazoxane Use in Pediatric Patients with Acute Lymphoblastic or Myeloid Leukemia: Analysis of a National Cohort of Patients in the Pediatric Health Information Systems Database From 1999 to 2009

Vitamin E Does Not Reduce Cardiomyopathy In Doxorubicin treated Rats

Transfusional Iron Overload: An Underappreciated Danger in AML Patients?

Prevention Effects of Schisandrin B on Cardiotoxicity Induced by Anthracyclines in Rabbit Model

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

Results of Randomized Study on Dexrazoxane Administration in Children with De Novo Acute Leukaemia.

Natriuretic Peptides in Children with Acute Lymphoblastic Leukaemia.

Thrombopoietin Protects Against Cardiotoxicity Induced by Doxorubicin.

Outcome of Dana-Farber Cancer Institute (DFCI) Consortium Protocol 95–01 for Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only